Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 668
Selected: 0
NCT IDTitle
NCT03141060Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in HIV-Infected and HIV-Uninfected Children With MDR-TB
NCT06931080Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
NCT00805454Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712
NCT02442674A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia
NCT05248646Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN)
NCT01994473Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
NCT04786574A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
NCT04649073Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma
NCT01660256Confirmatory Study of OPC-12759 Ophthalmic Solution
NCT01002950Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy
NCT01228682Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice
NCT01481142Adacolumn in Refractory UC Patients Trial
NCT00338273A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
NCT01111565Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
NCT04244253A Phase 2 Trial of OPC-64005 for Major Depressive Disorder
NCT00095719Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia
NCT04174365Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder
NCT03130465Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia
NCT04784442A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia
NCT03048747A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH
NCT03470233Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB
NCT07166796a Phase I PK Study in Healthy Male Subjects. 2 Groups of Healthy Male Subjects
NCT02827513A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects
NCT07086313A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
NCT03902574Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg
NCT01727713Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT01026584Efficacy and Safety of Aripiprazole in First Episode Psychosis
NCT07058233Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial
NCT02237417Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism
NCT01565018Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects
NCT04782258A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD)
NCT01114828A Study to Investigate Pharmacodynamics and Pharmacokinetics of OPC-41061 in Patients With Hepatic Edema
NCT04030143A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder
NCT05189977A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline
NCT01214421Tolvaptan Extension Study in Participants With ADPKD
NCT03906695Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic Syndromes
NCT01623154POCone-UBiT-IR300 Pediatric Comparison Study
NCT06928142A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's
NCT03487783Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome
NCT05402111A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard
NCT02722863Samsca Post Marketing Surveillance Study
NCT02293993Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia
NCT01360632Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
NCT02183792Aquaresis Utility for Hyponatremic Acute Heart Failure Study
NCT04241965A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870
NCT05221502Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
NCT03259555A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder
NCT00841568A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]
NCT06799520A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)
NCT01416441Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder